CFTR Chloride Channel Drug Discovery - Inhibitors as Antidiarrheals and Activators for Therapy of Cystic Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|18|2235-2247

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.18, 2006-06, pp. : 2235-2247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On the Discovery and Development of CFTR Chloride Channel Activators

By  

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 471-484

Bentham Science Publishers

Access to resources Recommend Favorite

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B.   Machen T.E.   Widdicombe J.   Fischer H.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

PDE5 inhibitors for cystic fibrosis: can they also enhance chloride transport?

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 965-968

Informa Healthcare

Access to resources Recommend Favorite

Cystic Fibrosis and the Use of Pharmacogenomics to Determine Surrogate Endpoints for Drug Discovery

By Eidelman O.   Zhang J.   Srivastava M.   Pollard H.B.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 3, 2001-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Cystic Fibrosis: Pathophysiology and Drug Discovery)

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 2, 2017-08 ,pp. : 80-81

Bentham Science Publishers

Access to resources Recommend Favorite